NASDAQ:ALDX

Aldeyra Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy ALDX

*Your capital is at risk

$1.64

-0.0200 (-1.20%)

At Close: Jun 02, 2026

Currently predicting for Thu, 4 Jun 2026

ALDX Prediction Chart

ALDX Predictions History

Latest community submissions for ALDX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PumpTheseNumbers Pro	Mar 27, 2019	$9.39 +0.21%	$9.37	X	99.79%	5
Nick	Aug 19, 2016	$5.30 -3.81%	$5.51	X	96.20%	0
Kerry.Prasifka.619	Aug 19, 2016	$4.84 -12.16%	$5.51	X	87.80%	0
Stockdum Senior	Aug 19, 2016	$5.85 +6.17%	$5.51	X	93.80%	0
JS Pro	Aug 19, 2016	$5.52 +0.18%	$5.51	X	99.80%	5
StockInvest Amateur	Jul 19, 2016	$5.75 +2.68%	$5.60	X	97.30%	0
Yash @Yash.378	Jul 19, 2016	$6.03 +7.68%	$5.60	X	92.30%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALDX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ALDEYRA THERAPEUTICS

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by